Serina Therapeutics, Inc. SER
1.48 USD +0.05 (+3.15%)
Nov 11, 2026, 9:38 AM EST
Day range unavailable
1.14 52-week range 4.26
- YTD
- -22.77%
- 1 year
- -63.85%
News
globenewswire.com Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC) Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an additional broad therapeutic opportunity for…
benzinga.com Serina Therapeutics Receives Recommendation From Independent Safety Monitoring Committee To Continue Its Phase 1b Registrational Trial Of SER-252 To Cohort 2 Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today…
benzinga.com Serina Therapeutics Q2 EPS $(0.55) Misses $(0.47) Estimate, Sales $130.000K, Same YoY Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.47) by 19.57 percent. This is a 16.67 percent increase over losses of…
benzinga.com Serina Therapeutics Completes Enrollment And Dosing In Cohort 1 Of Ongoing Phase 1b Registrational Clinical Trial Evaluating SER-252 In Patients With Advanced Parkinson’s Disease - All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 -- Independent Safety Monitoring Committee to review Cohort 1 safety…- benzinga.com BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8 BTIG analyst Thomas Shrader initiates coverage on Serina Therapeutics (AMEX:SER) with a Buy rating and announces Price Target of $8.
benzinga.com Gannet BioChem To Support Development Activities For SER-252, Serina Therapeutics' Investigational Therapy For Advanced Parkinson's Disease Gannet BioChem, a leading life sciences manufacturing company, today announced a development partnership with Serina Therapeutics, Inc. (NYSE:SER), a clinical-stage biotechnology company advancing…
benzinga.com Serina Therapeutics Files Prospectus For Offering 16.45M Common Shares On Behalf Of Selling Stockholders https://www.sec.gov/Archives/edgar/data/1708599/000149315226025007/forms-3.htm- benzinga.com Serina Therapeutics Says Phase 1b Registrational Clinical Study of SER-252 Underway In Advanced Parkinson's Disease; TFL Data From The SAD Study Arm Targeted For First Half of 2027 SER-252 Phase 1b Registrational Clinical Study: Following dosing of the first patient in February 2026, Serina continues to advance its Phase 1b registrational clinical study of SER-252 in advanced…
- benzinga.com Serina Therapeutics Q1 EPS $(0.58) Misses $(0.44) Estimate Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.44) by 31.82 percent. This is a 18.37 percent decrease over losses of…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED) (Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.) U.S. stock futures declined on Friday following Thursday’s declines. Futures of the major…- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Gold Tumbles Over 6%; Accenture Earnings Top Views 
benzinga.com Dow Falls Over 300 Points; US Initial Jobless Claims Fall US stocks down, Dow falls 300+ points, S&P 500 drops 0.93%, Nasdaq falls 1.25%. Energy shares up, materials down. Initial jobless claims down 8,000.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4 results and issuing strong FY26 EPS guidance. Other gainers include LBGJ, ASNS, SVRN, SUNE, MDAI,…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Xpeng, Serina Therapeutics, Dragonfly Energy Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why DarkIris Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Meta Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session